BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7046021)

  • 21. Hydrolysis of guinea pig nascent very low density lipoproteins catalyzed by lipoprotein lipase: activation by hjman apolipoprotein C-II.
    Fitzharris TJ; Quinn DM; Goh EH; Johnson JD; Kashyap ML; Srivastava LS; Jackson RL; Harmony JA
    J Lipid Res; 1981 Aug; 22(6):921-33. PubMed ID: 7276752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action of absorbable hypolipidemic drugs.
    Sirtori CR
    Adv Exp Med Biol; 1985; 183():241-52. PubMed ID: 4036700
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism of apolipoproteins and the metabolic heterogeneity of apo B in the rat.
    Marsh JB
    Adv Exp Med Biol; 1985; 183():99-112. PubMed ID: 4036707
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients.
    Matsuoka N; Shirai K; Johnson JD; Kashyap ML; Srivastava LS; Yamamura T; Yamamoto A; Saito Y; Kumagai A; Jackson RL
    Metabolism; 1981 Aug; 30(8):818-24. PubMed ID: 6894960
    [No Abstract]   [Full Text] [Related]  

  • 25. The mechanism of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants - a new theory.
    Felts JM; Itakura H; Crane RT
    Biochem Biophys Res Commun; 1975 Oct; 66(4):1467-75. PubMed ID: 172080
    [No Abstract]   [Full Text] [Related]  

  • 26. Triglyceridase and phospholipase A1 activities of rat-heart lipoprotein lipase. Influence of apolipoproteins C-II and C-III.
    Groot PH; Oerlemans MC; Scheek LM
    Biochim Biophys Acta; 1978 Jul; 530(1):91-8. PubMed ID: 210832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase.
    Shirai K; Barnhart RL; Jackson RL
    Biochem Biophys Res Commun; 1981 May; 100(2):591-9. PubMed ID: 7271774
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
    Kashyap ML; de Mendoza SG; Campbell M; Chen CY; Lutmer RF; Glueck CJ
    Experientia; 1978 Aug; 34(8):1044-5. PubMed ID: 212287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipoprotein metabolism].
    Biserte G; Fruchart JC
    Ann Biol Clin (Paris); 1973; 31(2):119-22. PubMed ID: 4356108
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of apolipoprotein C-II on the lipoprotein lipase-catalyzed hydrolysis of dihexanoyl- and diheptanoyl-phosphatidylcholine.
    Shinomiya M; Jackson RL
    Biochem Biophys Res Commun; 1983 Jun; 113(3):811-6. PubMed ID: 6870893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of lipoprotein lipase with phospholipid vesicles. Role of apolipoprotein C-II and heparin.
    Shirai K; Matsuoka N; Jackson RL
    Biochim Biophys Acta; 1981 Sep; 665(3):504-10. PubMed ID: 6895327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological regulation of lipoprotein lipase.
    Kersten S
    Biochim Biophys Acta; 2014 Jul; 1841(7):919-33. PubMed ID: 24721265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins.
    Krauss RM; Herbert PN; Levy RI; Fredrickson DS
    Circ Res; 1973 Oct; 33(4):403-11. PubMed ID: 4355035
    [No Abstract]   [Full Text] [Related]  

  • 34. Chylomicrons are the preferred substrate for lipoprotein lipase in vivo.
    Potts JL; Fisher RM; Humphreys SM; Coppack SW; Gibbons GF; Frayn KN
    Biochem Soc Trans; 1991 Aug; 19(3):314S. PubMed ID: 1783150
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles.
    Lambert DA; Catapano AL; Smith LC; Sparrow JT; Gotto AM
    Atherosclerosis; 1996 Dec; 127(2):205-12. PubMed ID: 9125310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein lipase. Mechanism of formation of triglyceride-rich remnant particles from very low density lipoproteins and chylomicrons.
    Higgins JM; Fielding CJ
    Biochemistry; 1975 Jun; 14(11):2288-93. PubMed ID: 166652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action.
    Sacks FM; Dzau VJ
    Am J Med; 1986 Feb; 80(2A):71-81. PubMed ID: 3080883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.
    Wolska A; Dunbar RL; Freeman LA; Ueda M; Amar MJ; Sviridov DO; Remaley AT
    Atherosclerosis; 2017 Dec; 267():49-60. PubMed ID: 29100061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the phospholipase A1 activity of lipoprotein lipase by apoprotein C-II.
    Stocks J; Galton DJ
    Lipids; 1980 Mar; 15(3):186-90. PubMed ID: 7374370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipoprotein metabolism].
    Corvilain B
    Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.